• Porter Novelli Life Sciences (San Diego) reported that it has hired Lynne Brum as executive VP in the agency's Boston office. Brum joined the agency from Vertex Pharmaceuticals. Porter Novelli Life Sciences describes itself as "the only dedicated life science PR firm."
  • David Conn has been named chief commercial officer of WaveSense (Salem, New Hampshire). Previously, Conn was president/CEO of Hypoguard. WaveSense makes diabetes products.

No Comments